View Older Stories View More Recent Stories

Aug 25, 2025 02:15AM RBC Capital Starts argenx SE (ARGX) at Outperform
Aug 4, 2025 04:14AM argenx SE (ARGX:BB) (ARGX) PT Raised to EUR655 at Deutsche Bank
Aug 1, 2025 08:05AM argenx SE (ARGX) PT Raised to $1,070 at Guggenheim
Aug 1, 2025 07:46AM argenx SE (ARGX) PT Raised to $796 at Scotiabank
Aug 1, 2025 06:50AM argenx SE (ARGX) PT Raised to $774 at H.C. Wainwright
Aug 1, 2025 05:46AM argenx SE (ARGX) PT Raised to $778 at Oppenheimer
Jul 31, 2025 12:51PM argenx SE (ARGX) PT Raised to $880 at BofA Securities
Jul 31, 2025 03:23AM argenx (ARGX) Reports Q2 EPS of $6.32
Jul 25, 2025 06:15AM argenx (ARGX) Added to BofA US 1 List
Jul 22, 2025 06:59AM 15 names that Morgan Stanley’s analysts expect to move meaningfully on earnings
Jul 15, 2025 06:06AM argenx SE (ARGX) PT Raised to $829 at BofA Securities
Jul 3, 2025 04:20AM Morgan Stanley Assumes argenx SE (ARGX) at Overweight
Jul 1, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
Jun 30, 2025 04:13PM Citi on argenx SE (ARGX): 'We remain Buyers on today’s weakness'
Jun 30, 2025 11:40AM argenx (ARGX) Weakness Said to be Tied to Negative FDA Report
Jun 11, 2025 09:31AM TD Cowen on argenx SE (ARGX): 'Sjogren's Shows Multi-Billion Potential'
Jun 10, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
May 28, 2025 06:50AM argenx (ARGX) Added to Wedbush Best Ideas List
May 21, 2025 09:00PM Recent pullback offers an attractive buying opportunity in this stock: Citi
May 14, 2025 04:08AM argenx SE (ARGX) PT Lowered to $699 at Citizens JMP
May 13, 2025 04:19AM Baird Upgrades argenx SE (ARGX) to Outperform
May 12, 2025 05:18AM argenx SE (ARGX:BB) (ARGX) PT Lowered to EUR525 at Deutsche Bank
May 9, 2025 09:40AM TD Cowen on argenx SE (ARGX): 'We View the Selloff as a Buying Opportunity'
May 9, 2025 06:22AM Leerink Partners on argenx SE (ARGX): 'Share Pullback Creates Buying Opp'ty'
May 8, 2025 03:11AM argenx (ARGX) Tops Q1 EPS by 34c
Apr 17, 2025 05:33AM TD Cowen Reiterates Buy Rating on argenx SE (ARGX)
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 11, 2025 07:08AM Stifel Reiterates Buy Rating on argenx SE (ARGX)
Apr 11, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
Apr 11, 2025 06:29AM Guggenheim Reiterates Buy Rating on argenx SE (ARGX)
Apr 10, 2025 06:02PM argenx (ARGX) announces FDA approval of VYVGART Hytrulo
Mar 17, 2025 01:12AM Bernstein SocGen Group Double Upgrades argenx SE (ARGX:BB) (ARGX) to Outperform
Mar 13, 2025 11:03AM TD Cowen Names argenx SE (ARGX) 'Europe Best Ideas'
Mar 12, 2025 07:09AM Deutsche Bank Upgrades argenx SE (ARGX:BB) (ARGX) to Hold
Mar 10, 2025 06:20AM argenx SE (ARGX) PT Raised to $1,100 at Guggenheim
Feb 28, 2025 07:04AM argenx SE (ARGX) PT Raised to $720 at H.C. Wainwright
Feb 28, 2025 04:07AM argenx SE (ARGX) PT Raised to $701 at Citizens JMP
Feb 27, 2025 05:37PM argenx SE (ARGX) PT Raised to $761 at TD Cowen
Jan 14, 2025 12:28PM argenx SE (ARGX) PT Raised to $717 at H.C. Wainwright
Jan 13, 2025 09:07AM argenx SE (ARGX) PT Raised to $700 at Truist Securities
Jan 13, 2025 07:18AM argenx SE (ARGX) PT Raised to $772 at Jefferies
Jan 7, 2025 07:45AM argenx SE (ARGX) PT Raised to $725 at Piper Sandler Following New Neurologist Surveys
Jan 4, 2025 04:00PM 2025 Biopharma sector outlook
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 9, 2024 07:33AM Piper Sandler Reiterates Overweight Rating on argenx SE (ARGX) Following Investor Dinner
Nov 22, 2024 11:07AM argenx SE (ARGX) PT Raised to $707 at Jefferies
Nov 21, 2024 05:08AM argenx SE (ARGX) PT Raised to $675 at Oppenheimer
Nov 21, 2024 01:40AM argenx SE (ARGX:BB) (ARGX) PT Raised to EUR670 at Barclays
Nov 20, 2024 03:57PM argenx SE (ARGX) PT Raised to $706 at Evercore ISI
Nov 20, 2024 11:44AM Late Morning $5 Dip in argenx SE (ARGX) Attributed to Raymond James Comments, 'we are introducing the myositis opportunity into our model'
View More Recent Stories View Older Stories